OBLIQUE THERAPEUTICS

DEAD

Serial Number

88178266

Owner

Oblique Therapeutics AB

Attorney

James F. Keenan, Jr

Filing Date

Nov 1, 2018

Add to watchlist:

No watchlists yet

+ Create New Watchlist

View on USPTO

OBLIQUE THERAPEUTICS Trademark

Serial Number: 88178266

OBLIQUE THERAPEUTICS is a trademark filed by Oblique Therapeutics AB on November 1, 2018. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently no longer active.

Trademark Classes

Class 5 - Pharmaceuticals

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Owner Contact Info

Oblique Therapeutics AB (4 trademarks)

Arvid Wallgrens Backe 20
413 46 Göteborg 41346 , SE

Entity Type: 99

Legal Representation

Attorney of Record

James F. Keenan, Jr

3,955 trademarks filed View all →

Correspondence Address

James F. Keenan, Jr. BERNSTEIN, SHUR, SAWYER & NELSON

100 MIDDLE STREET

PORTLAND

ME 04104

UNITED STATES

Trademark Details

Filing Date

November 1, 2018

Registration Date

Not Registered

Published for Opposition

January 7, 2020

Filing History

ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED

Apr 3, 2023 MAB6

ABANDONMENT - NO USE STATEMENT FILED

Apr 3, 2023 ABN6

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Sep 8, 2022 EXRA

SOU EXTENSION 5 GRANTED

Sep 7, 2022 EX5G

CASE ASSIGNED TO INTENT TO USE PARALEGAL

Sep 7, 2022 AITU

SOU EXTENSION 5 FILED

Aug 25, 2022 EXT5

SOU TEAS EXTENSION RECEIVED

Aug 25, 2022 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Mar 1, 2022 EXRA

SOU EXTENSION 4 GRANTED

Feb 25, 2022 EX4G

SOU EXTENSION 4 FILED

Feb 25, 2022 EXT4

SOU TEAS EXTENSION RECEIVED

Feb 25, 2022 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Sep 1, 2021 EXRA

SOU EXTENSION 3 GRANTED

Aug 30, 2021 EX3G

SOU EXTENSION 3 FILED

Aug 30, 2021 EXT3

SOU TEAS EXTENSION RECEIVED

Aug 30, 2021 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

Mar 4, 2021 EXRA

SOU EXTENSION 2 GRANTED

Mar 2, 2021 EX2G

SOU EXTENSION 2 FILED

Mar 2, 2021 EXT2

SOU TEAS EXTENSION RECEIVED

Mar 2, 2021 EEXT

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED

May 1, 2020 EXRA

SOU EXTENSION 1 GRANTED

Apr 29, 2020 EX1G

SOU EXTENSION 1 FILED

Apr 29, 2020 EXT1

SOU TEAS EXTENSION RECEIVED

Apr 29, 2020 EEXT

NOA E-MAILED - SOU REQUIRED FROM APPLICANT

Mar 3, 2020 NOAM

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

Jan 7, 2020 NPUB

PUBLISHED FOR OPPOSITION

Jan 7, 2020 PUBO

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

Dec 18, 2019 NONP

ASSIGNED TO LIE

Dec 4, 2019 ALIE

APPROVED FOR PUB - PRINCIPAL REGISTER

Dec 2, 2019 CNSA

TEAS/EMAIL CORRESPONDENCE ENTERED

Nov 26, 2019 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

Nov 26, 2019 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

Nov 26, 2019 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Jun 3, 2019 GNRN

NON-FINAL ACTION E-MAILED

Jun 3, 2019 GNRT

NON-FINAL ACTION WRITTEN

Jun 3, 2019 CNRT

TEAS/EMAIL CORRESPONDENCE ENTERED

May 20, 2019 TEME

CORRESPONDENCE RECEIVED IN LAW OFFICE

May 20, 2019 CRFA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

May 20, 2019 TROA

NOTIFICATION OF NON-FINAL ACTION E-MAILED

Feb 7, 2019 GNRN

NON-FINAL ACTION E-MAILED

Feb 7, 2019 GNRT

NON-FINAL ACTION WRITTEN

Feb 7, 2019 CNRT

ASSIGNED TO EXAMINER

Feb 7, 2019 DOCK

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

Nov 16, 2018 NWOS

NEW APPLICATION ENTERED

Nov 5, 2018 NWAP

Related Trademarks

More from this Owner

OBLIQUE THERAPEUTICS

More in Same Class

3 CATARACTIVE3

BRIXADI